Myocardial infarction as a mask for catecholamine-induced cardiomyopathy against the background of pheochromocytoma
https://doi.org/10.21886/2712-8156-2023-4-2-115-121
Abstract
Pheochromocytoma (PC) is a tumor of chromaffin cells of the sympathetic-adrenal system that produces a large amount of catecholamines (adrenaline, norepinephrine, dopamine). There are no reliable data in the literature on the frequency of cardiac manifestations of pheochromocytoma, which is associated with the rarity of this pathology. This case demonstrates the development of catecholamine-induced cardiomyopathy, proceeding under the guise of a heart attack, as the primary manifestation of pheochromocytoma. The patient was referred with a diagnosis of «Ischemic heart disease, myocardial infarction» to perform coronary angiography, according to the result of the study, no pathology of the coronary arteries was detected. In the process of additional examination, a pheochromocytoma of the left adrenal gland was revealed. The initial changes in the electrocardiogram, echocardiographic examination, and laboratory parameters regressed, which confirmed the development of cardiomyopathy that developed against the background of pheochromocytoma. Currently, there is an increasing amount of information about non-ischemic myocardial damage in patients with pheochromocytoma. These changes in the form of clinical manifestations (pain behind the sternum, shortness of breath, various types of arrhythmias) as well as non-specific changes according to ECG data, disturbances of local kinetics with a decrease in global myocardial contractility without stenotic damage to the coronary artery were called catecholamine-induced cardiomyopathy.
About the Authors
N. A. LigayRussian Federation
Natalya A. Ligay - cardiologist of the regional vascular center, Rostov Regional Clinical Hospital.
Rostov-on-Don
M. S. Lankina
Russian Federation
Maria S. Lankina - Cand. Sci. (Med.), Associate Professor of the Department of Internal Medicine No. 1 of the Rostov State Medical University.
Rostov-on-Don
I. A. Bagaeva
Russian Federation
Inna A. Bagaeva - head of the cardiology department of the regional vascular center, Rostov Regional Clinical Hospital.
Rostov-on-Don
A. V. Khripun
Russian Federation
Alexey V. Khripun - Cand. Sci. (Med.), Associate Professor of the Department of Internal Diseases No. 1 of the Rostov State Medical University, Chief Freelance Cardiologist of the Ministry of Health of the Rostov Region, Deputy Chief Physician for the Medical Department of the Rostov Regional Clinical Hospital, Director of the Regional Vascular Center.
Rostov-on-Don
A. I. Chesnikova
Russian Federation
Anna I. Chesnikova - Dr. Sci. (Med.), Professor, Professor of the Department of Internal Medicine No. 1, Rostov State Medical University, chief freelance therapist of the Southern Federal District.
Rostov-on-Don
References
1. Davis MA, Bove GM. A case of pheochromocytoma presenting as low back pain. J Manipulative Physiol Ther. 2007;30(8):598-601. doi: 10.1016/j.jmpt.2007.06.009
2. Zhang R, Gupta D, Albert SG. Pheochromocytoma as a reversible cause of cardiomyopathy: Analysis and review of the literature. Int J Cardiol. 2017;249:319-323. doi: 10.1016/j.ijcard.2017.07.014
3. Zelinka T, Petrak O, Turkova H, Holaj R, Strauch B, Krsek M, et al. High incidence of cardiovascular complications in pheochromocytoma. Horm Metab Res. 2012;44(5):379-84. doi: 10.1055/s-0032-1306294
4. Kassim TA, Clarke DD, Mai VQ, Clyde PW, Mohamed Shakir KM. Catecholamine-induced cardiomyopathy. Endocr Pract. 2008;14(9):1137-49. doi: 10.4158/EP.14.9.1137
5. Lyon AR, Bossone E, Schneider B, Sechtem U, Citro R, Underwood SR, et al. Current state of knowledge on Takotsubo syndrome: a Position Statement from the Taskforce on Takotsubo Syndrome of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2016;18(1):8-27. doi: 10.1002/ejhf.424
6. Prasad A, Lerman A, Rihal CS. Apical ballooning syndrome (Tako-Tsubo or stress cardiomyopathy): a mimic of acute myocardial infarction. Am Heart J. 2008;155(3):408-17. doi: 10.1016/j.ahj.2007.11.008.
7. Ghadri JR, Wittstein IS, Prasad A, Sharkey S, Dote K, Akashi YJ, et al. International Expert Consensus Document on Takotsubo Syndrome (Part II): Diagnostic Workup, Outcome, and Management. Eur Heart J. 2018;39(22):2047-2062. doi: 10.1093/eurheartj/ehy077
8. Болдуева С.А., Евдокимов Д.С. Кардиомиопатия такоцубо. Обзор данных литературы: понятие, эпидемиология, патогенез. Часть I. Российский кардиологический журнал. 2022;27(3S):4993. DOI: 10.15829/1560-4071-2022-4993
9. Gagnon N, Mansour S, Bitton Y, Bourdeau I. Takotsubo-like cardiomyopathy in a large cohort of patients with pheochromocytoma and paraganglioma. Endocr Pract. 2017;23(10):1178-1192. doi: 10.4158/EP171930.OR
10. Agarwal V, Kant G, Hans N, Messerli FH. Takotsubo-like cardiomyopathy in pheochromocytoma. Int J Cardiol. 2011;153(3):241-8. doi: 10.1016/j.ijcard.2011.03.027.
11. Y-Hassan S. Clinical Features and Outcome of Pheochromocytoma-Induced Takotsubo Syndrome: Analysis of 80 Published Cases. Am J Cardiol. 2016;117(11):1836-44. doi: 10.1016/j.amjcard.2016.03.019
Review
For citations:
Ligay N.A., Lankina M.S., Bagaeva I.A., Khripun A.V., Chesnikova A.I. Myocardial infarction as a mask for catecholamine-induced cardiomyopathy against the background of pheochromocytoma. South Russian Journal of Therapeutic Practice. 2023;4(2):115-121. (In Russ.) https://doi.org/10.21886/2712-8156-2023-4-2-115-121